The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dzampaev A.T.

Gorodskaia klinicheskaia bol'nitsa im. S.P. Botkina, Moskva

Suvorova I.A.

Irkutskiĭ gosudarstvennyĭ institut usovershenstvovaniia vracheĭ

Damulin I.V.

kafedra nervnykh bolezneĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Clinical potential and possibilities of using buspirone in the treatment of anxiety disorders

Authors:

Dzampaev A.T., Suvorova I.A., Damulin I.V.

More about the authors

Views: 1439

Downloaded: 40


To cite this article:

Dzampaev AT, Suvorova IA, Damulin IV. Clinical potential and possibilities of using buspirone in the treatment of anxiety disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(8):94‑104. (In Russ.)

Recommended articles:
Prevalence of cognitive impairment in older adults in the Russian Fede­ration. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11
Pharmacotherapy of schi­zophrenia: clinical and some age-related aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):41-50
Epidemiology of suicidal beha­vior in children and adolescents worldwide. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):16-26
Preadolescent acne. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(2):175-180
Epidemiology of acute poisoning in pediatric practice. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):58-66
Leading trends in breast cancer inci­dence in the Repu­blic of Crimea. P.A. Herzen Journal of Onco­logy. 2024;(4):42-47

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.